204 related articles for article (PubMed ID: 31646553)
21. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
Chen SG; Wang CH; He RQ; Xu RY; Ji CB
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
[TBL] [Abstract][Full Text] [Related]
22. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
23. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
Gong YB; Zou YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
[TBL] [Abstract][Full Text] [Related]
24. MiR-200a promotes cell invasion and migration of ovarian carcinoma by targeting PTEN.
Suo HB; Zhang KC; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4080-4089. PubMed ID: 30024595
[TBL] [Abstract][Full Text] [Related]
25. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma.
Yu BX; Zou L; Li S; Du YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8456-8467. PubMed ID: 31646576
[TBL] [Abstract][Full Text] [Related]
26. Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN/AKT signaling pathway.
Zhang Q; Len TY; Zhang SX; Zhao QH; Yang LH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):43-54. PubMed ID: 31957817
[TBL] [Abstract][Full Text] [Related]
27. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
Yang Q; Yu Y; Sun Z; Pan Y
Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
[TBL] [Abstract][Full Text] [Related]
29. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
Xu QF; Tang YX; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
[TBL] [Abstract][Full Text] [Related]
30. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
31. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
[No Abstract] [Full Text] [Related]
32. Highly expressed lncRNA FAL1 promotes the progression of gastric cancer by inhibiting PTEN.
Zhu CH; Xiao DH; Dai LG; Xu HG; Jiang YH; Zheng ZJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8257-8264. PubMed ID: 30556865
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
Luan X; Wang Y
Oncol Rep; 2017 Jul; 38(1):159-166. PubMed ID: 28534991
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
36. LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
Zhang D; Du D; Yi S; Li X
Ann Diagn Pathol; 2020 Dec; 49():151642. PubMed ID: 33142195
[TBL] [Abstract][Full Text] [Related]
37. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
Chang S; Chen B; Wang X; Wu K; Sun Y
BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
